Treatment-resistant depression: therapeutic trends, challenges, and future directions

Cited by (794)

Items 701–794 of 794

1. The psychological impact of non-responsiveness to antidepressants on patients with depression and the role of pharmacogenomics-based drug therapy
   C. Agbo, U. Chima, C. Nwachuya, N. V. Enang, C. Okoye, Sylvia M. Mbaji, Ngozi M. Uzokwe, A. P. Ngige, O. Iwuchukwu, Andrea Okoloekwe · 2023 · American Journal of Pharmacotherapy and Pharmaceutical Sciences
2. Cortical network mechanisms in subcallosal cingulate deep brain stimulation for depression
   Maximilian Scherer, Irene E. Harmsen, Nardin Samuel, Gavin J.B. Elias, Jürgen Germann, Alexandre Boutet, C. E. MacLeod, Peter Giacobbe, NC Rowland, Andrés M. Lozano et al. · 2023 · medRxiv
3. Comments on “A Collaborative-Care Telephone-Based Intervention for Depression, Anxiety, and at-Risk Drinking in Primary Care: The PARTNERs Randomized Clinical Trial”
   Imamuddin Khan, Nishtha Chawla · 2023 · The Canadian Journal of Psychiatry
4. A Close Look at Echium amoenum Processing, Neuroactive Components, and Effects on Neuropsychiatric Disorders
   Mostafa Araj‐Khodaei, Mohammad Nouri, Fereshteh Farajdokht, Mohammadali Torbati, Fatemeh Ranjbar Kuchaksaray, Sanaz Hamedyazdan, Saeed Sadigh‐Eteghad · 2019 · Galen Medical Journal
5. The Efficacy of Low-Dose Esketamine and Butorphanol in Treating Depression and Pain After Cesarean Section
   Chunyan Zhao, Xiaofen Liu, Cibo Chen, Hongmei Yang, Bingchun Xia · 2023 · Advances in Obstetrics and Gynecology Research
6. Prevalence and National Patterns of Commonly Prescribed Antidepressants and other Psychotropic Medications to patients with treatment-resistant depression in France
   Vimont Alexandre, Margot Biscond, H Leleu, Marina Sánchez Rico, Nicolas Hoertel, Pierre‐Michel Llorca · 2024 · medRxiv
7. Non-Cognitive Disorders in Older Patients
   Juan Joseph Young · 2024 · Elsevier eBooks
8. Mood Disorders in the Twenty-First Century
   Allan Hunter Young, Marsal Sanches, Jair C. Soares, Mário F. Juruena · 2024 · Cambridge University Press eBooks
9. Therapeutic Choices
   Eliana Nogueira-Vale · 2024 · Springer eBooks
10. Investigation of Herb-Drug Interactions between Xylopia aethiopica, Its Principal Constituent Xylopic Acid, and Antidepressants
    Christian Chukwuma Ndu, Wonder Kofi Mensah Abotsi, Priscilla Kolibea Mante · 2024 · Advances in Pharmacological and Pharmaceutical Sciences
11. Combination Therapies in Depression: Evaluating the Synergy of Antidepressants and Adjunctive Treatments
    Anjali Rana, Prabhjeet Kaur Bamrah, Priyanak, Harsh Gautam · 2024 · International Journal of Pharma Professional’s Research (IJPPR)
12. Physical activity in the treatment-resistant depression and non-remitted depression: a systematic review of randomized controlled trials
    José Etxaniz‐Oses, Nagore Iriarte‐Yoller, Mikel Tous‐Espelosin, Sara Maldonado‐Martín · 2024 · F1000Research
13. Study Assessing Use of Mood Stabilizers (Sodium Valproate and Oxcarbazepine) as an Augmentation Strategy in Patients of Treatment-resistant Depression
    Priya Chugh, Fiona Mahapatro · 2024 · Annals of Indian Psychiatry
14. Physical activity in the treatment-resistant depression and non-remitted depression: a systematic review of randomized controlled trials
    José Etxaniz‐Oses, Nagore Iriarte‐Yoller, Mikel Tous‐Espelosin, Sara Maldonado‐Martín · 2024 · F1000Research
15. Effects of Ketamine and Esketamine on Cognitive Functions in Treatment-Resistant Depression
    Mahir Mutlu, Çağrı Öven, Bilge Sena Kurt, Emre SUNAY · 2024 · Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry
16. A localized tracing technique to explore intra-amygdala functional and structural correlates of individual variability in behavioral response
    Allie B. Lipshutz, Victoria Saltz, Kristin R. Anderson, Alessia Manganaro, Dani Dumitriu · 2025 · Frontiers in Molecular Neuroscience
17. Effects of Edgeworthia chrysantha Lindl. Extract on BDNF and its Receptor TrkB in the Hippocampus of Depression Model Rats
    Yueting Liu, Shimin Wu, Shutong Miao, Lu Yan, Zixuan Huang, Gang Fang, Yun Zhang, Qiuyu Feng · 2025 · Natural Product Communications
18. Supervised Machine-Learning Classification of Treatment-Resistant Depression in U.S. Claims Data
    Vicki K. Wing, Jason Lerner, Patrick Clarke, Shane J. O’Connor, Sydney Tran, Jonathan D. Darer, Jaspreet Singh Gill, Lucinda Strycker Orsini · 2025 · medRxiv
19. A retrospective analysis of combined treatment with escitalopram and Naoan dropping pills treatment for depression
    Xiaoyan Wang, Yan Che, Wenli Wang · 2025 · Medicine
20. Breaking the chains of depression: innovative strategies for treatment, adherence, and well-being
    Venkata Nagaraju Gorre, Likhita Gayatri P, Mariyabi SK, G Nandini, Suhana Parveen Patan · 2025 · International Journal of Current Innovations in Advanced Research
21. C-reactive Protein as an Indicator for Antidepressant Response in Late-Onset Depression
    Umesh Pratap Singh, Dheerendra Kumar Mishra, Ujwal Sardesai · 2025 · Cureus
22. Candidate gene studies of suicidal behavior-3: in relation to dopaminergic polymorphisms
    Subir Ranjan Kundu, Jaya Sarkar · 2025 · Elsevier eBooks
23. Turbulent-like Dynamics Predict Treatment Outcome in Major Depressive Disorder
    Henricus Gerardus Ruhé, Maarten G. Poirot, Yonatan Sanz Perl, Matthan W.A. Caan, Henk A. Marquering, Gustavo Deco, Morten L. Kringelbach, Liesbeth Reneman · 2025 · Research Square
24. Esketamine for Treatment-Resistant Depression: A Case Series and Literature Review
    Muhammad Abbas, David B. Adams, Jack Noto, Renzmark D Vallesteros, Talitha West · 2025 · Cureus
25. Sildenafil, alleen en in kombinasie met imipramien, vertoon antidepressantagtige effekte in ’n tydafhanklikesensitiseringgeïnduseerde (TAS-) rotmodel van behandelingsweerstandige depressie
    Juandré Lambertus Bernardus Saayman, Brian Herbert Harvey, G Wegener, Christiaan Beyers Brink · 2024 · Suid-Afrikaanse Tydskrif vir Natuurwetenskap en Tegnologie
26. Sildenafil, alone and in combination with imipramine, displays antidepressant-like effects in a time-dependent sensitisation-induced (TDS) rat model of treatment-resistant depression
    Juandré Lambertus Bernardus Saayman, Brian Herbert Harvey, G Wegener, Christiaan Beyers Brink · 2024 · Suid-Afrikaanse Tydskrif vir Natuurwetenskap en Tegnologie
27. Integrating multi-polygenic scores for enhanced prediction of antidepressant treatment outcomes in an East Asian population
    Shu-Chin Lin, Chiu-Ping Fang, Chia-Lin Hsu, An-Nie Chung, Tzu-Ting Chen, Kai-Hsiang Hsu, Chueh-Chun Yeh, Jingyi Zheng, Chao-Yu Liu, Chi-Shin Wu et al. · 2025 · Neuropsychopharmacology
28. Taurine and Bupropion Co-Administration in Depression: A CUMS-Based Preclinical Study
    Akash Gupta, Arwa Mithaiwala, Angel Pavalu Godad · 2025 · Research Square
29. Effect of encapsulated spice oleoresins on chronic unpredictable mild stress-induced depression and gut microbiome modulation in mice model
    Rajashri Kulal, Mohammed Touseef Khan, Babasaheb Bhaskarrao Borse, Muthukumar Serva Peddha · 2025 · Nutritional Neuroscience
30. ANTIDEPRESSANT ACTIVITY OF PERICARPIUM GRANATI PEELS IN ALBINO MICE-A BENEFICIAL HERBAL TREATMENT STRATEGY
    Aman Sharma, AJEET PAL SINGH, Amar Pal Singh, Mamta Kumari · 2025 · International Journal of Current Pharmaceutical Research
31. Chronic administration of berberine attenuates depressive-like behavior in rats subjected to chronic unpredictable mild stress combined with ACTH treatment: Role of nitrergic system
    Sharvari Deshmukh, Biru B. Dudhabhate, Dipak K Sahare, Dadasaheb M. Kokare, Yashashree A. Gadhikar · 2025 · Behavioural Brain Research
32. Additional file 1 of The Precision in Psychiatry (PIP) study: Testing an internet-based methodology for accelerating research in treatment prediction and personalisation
    Lee, Chi Tak, Jorge E. Palacios, Richards, Derek, Anna Kathleen Hanlon, Kevin Lynch, Siobhán Harty, Nathalie Claus, Lorraine Swords, Veronica O’Keane, Klaas Enno Stephan et al. · 2023 · Figshare
33. The Gut-Brain Axis: The effect of dysbiosis on mood disorders like anxiety and depression
    Mirra Sangal · 2022 · Journal of High School Science
34. Additional file 2 of The Precision in Psychiatry (PIP) study: Testing an internet-based methodology for accelerating research in treatment prediction and personalisation
    Lee, Chi Tak, Jorge E. Palacios, Richards, Derek, Anna Kathleen Hanlon, Kevin Lynch, Siobhán Harty, Nathalie Claus, Lorraine Swords, Veronica O’Keane, Klaas Enno Stephan et al. · 2023 · Figshare
35. Additional file 1 of Nationwide consensus on the clinical management of treatment-resistant depression in Italy: a Delphi panel
    Giuseppe Maina, Adami, Marina, Ascione, Giuseppe, Emi Bondi, Domenico De Berardis, Dario Delmonte, Silvia Maffezzoli, Martinotti, Giovanni, Nivoli, Alessandra, Elena Ottavianelli et al. · 2024 · Figshare
36. UK Medical Cannabis Registry: A two-year case series of clinical outcomes in depression
    Elizabeth Lillywhite, Simon Erridge, Evonne Clarke, Katy McLachlan, Ross Coomber, Muhammed Asghar, Urmila Bhoskar, Matthieu Crews, Andrea De Angelis, Muhammad Imran et al. · 2026 · Journal of Affective Disorders
37. Physical activity in the treatment-resistant depression and non-remitted depression: a systematic review of randomized controlled trials
    José Etxaniz‐Oses, Nagore Iriarte‐Yoller, Mikel Tous‐Espelosin, Sara Maldonado‐Martín · 2025 · F1000Research
38. Cognitive bias modification for emotional facial expressions modifies neural mechanisms in individuals taking antidepressant medication: a Randomised Controlled Trial
    Charlotte Crisp, Sean James Fallon, Alison Burns, Rumeysa Kuruoğlu, Jennifer Ferrar, Nicola Wiles, David S. Kessler, Marcus Robert Munafo, I. M. Penton-Voak · 2026 · medRxiv
39. Analysis of the correlation between the expression levels of caspase-1/IL-1β in the peripheral blood and clinical efficacy in patients with first-episode MDD
    Jing-Yang Gu, Dong-Chuan Di, Meng-Yue Gu, Huanzhong Liu · 2026 · Annals of General Psychiatry
40. Assessment of Anti-depressant-Induced Self-Reported Adverse Drug Reactions Among Patients in a Tertiary Care Hospital in Nepal: A Cross-Sectional Study
    Ajaya K Acharya, Durga Bista, Barsha Shrestha, Sunil Shrestha, Rajani Shakya · 2026 · Drugs - Real World Outcomes
41. The role of gene-environment interactions in endocrine-sensitive life stages for shaping mental health: focus on the RE-MEND project
    Khawla Abualia, Andrea Cediel-Ulloa, Philip J. Allsopp, Angelika A. Augustine, Jonas Bergquist, Carl‐Gustaf Bornehag, Karin Bröberg, Nicolò Caporale, Erika Comasco, Diego di Bernardo et al. · 2026 · Frontiers in Psychiatry
42. Gold nanoparticles for central nervous system drug delivery in depression: nanobiological mechanisms, pharmacokinetics and translational perspectives
    Zofia Śledzikowska, Dominika Kubicka, Natalia Makaruk, N. Waszkiewicz · 2026 · Health Nanotechnology
43. Lived Experiences and Engagement in an Exercise Program for People with Resistant Major Depression: TRACE-RMD Study
    José Etxaniz‐Oses, Mikel Tous‐Espelosin, Pedro M. Sanchez, Sara Maldonado‐Martín, Ana Isabel Prada-Perea, Nagore Iriarte‐Yoller · 2026 · Healthcare
44. Reversal strategies within the lateral habenula to ameliorate depressive-like behaviors
    Anna Tchenio · 2017 · theses.fr (ABES)
45. The beliefs associated with alcohol and their link with traumatic experiences and several psychological disorders in Saudi Arabia : an exploratory research
    Raghdah Tammar · 2017
46. Neuropathic pain and depression : molecular alterations in the anterior cingulate cortex
    Muris Humo · 2019 · theses.fr (ABES)
47. Etude de la voie de la kynurénine dans la symptomatologie du sujet obèse
    Lison Huet · 2019 · theses.fr (ABES)
48. The role of gut microbiome in the pathophysiology of PTSD, depression, and anxiety disorders
    Nto Johnson Nto, Walter Pirovano, Kristien Nel Van Zyl, Stefanie Malan‐Müller, Emma Koch, Matsepo C. Ramaboli, Dineo Madikgetla, Christiaan de Leeuw, Christopher A. Lowry, Sian M. J. Hemmings · 2026 · Gut Microbes Reports
49. Comparison of average time-to-relapse following ECT versus ketamine – A systematic review
    Minna Chang, Allan Hunter Young, Mário F. Juruena · 2026 · Journal of Psychopharmacology
50. Transcutaneous vagus nerve stimulation enhances reward-effort efficiency in major depressive disorder
    Paul Forbes, Emily S.L. Brandt, Mareike Aichholzer, Carmen Uckermark, Aicha Bouzouina, Leona Jacobsen, Jonathan Repple, Jonathan Kingslake, Christine Reif-Leonhard, Andreas Reif et al. · 2026 · medRxiv
51. Top 50 Cited Articles on the Treatment of Major Depressive Disorder
    Ahmed A Albesher, Nayef A Muflehi, Yazan A Hakami, Jana A Barnawi, Randah E Softah, Luluwah H Al Ghalib, Mayar Bukhari, Reem Abdulaziz M. Almotiri, Maha S Algethami, Shahad W Mahboob et al. · 2026 · Cureus
52. Basic and clinical research on acupuncture for post-stroke depression: A narrative review
    Wei Xie, Zhong Di, Wei Shao, Ai-Jun Wang, Lihua Guan · 2026 · World Journal of Methodology
53. A Deep-Learning Approach Based on BERT Model for Depression Severity Prediction
    Ngonidzashe Mathew Kanyangarara, Madhu Chetty, Jiangang Ma · 2026 · Lecture notes in computer science
54. Psychiatric safety of methylphenidate in adults with major depressive disorder: a 1-year retrospective cohort study of 6,422 patients
    Ting-Hui Liu, Ya-Lin Huang, Jheng-Yan Wu, Chien-Ho Lin, Fong-Lin Jang, Chih-Cheng Lai · 2026 · Psychological Medicine
55. Disc1 Gene Expression as a Blood Biomarker for Major Depressive Disorder: A Comparative Study of Fluoxetine and Cognitive-Behavioral Therapy
    Ali Barzegar, Mehdi Pourasghar, Mohammad Bagher Hashemi‐Soteh, Bahareh Baki, Hossein Ghalehnoei · 2026 · Neurochemical Journal
56. Heart Rate Metrics as Potential Biomarkers for Predicting Transcranial Magnetic Stimulation Treatment Response in Treatment-Resistant Depression
    Hsin‐An Chang, Chin‐Kuo Chang, Ting-Yin Lai, Hu‐Ming Chang, Yi-Ching Liu, Alexander Thomas Sack · 2026 · Research Square
57. Hydroalcoholic Extract of Ferula aucheri Shows Anti-depressant Effect Against Lipopolysaccharide-Induced Depression in Mice: Involvement of NF-κB and TLR4 Signaling Pathway
    Mohammad Mehdi Gravandi, Maryam Naseri, Nasim Jamshidi, Samira Shirooie · 2026 · Iranian journal of pharmaceutical research
58. Hidden Psychiatric Effects: New Findings on Adult Survivors of Childhood Leukemia Chemotherapy
    Parrthvi Arora, Jimeet Gadhvi, Dev Desai, Suprakash Chaudhury, Mukesh K. Patel, Raahat Kapur · 2026 · Medical Journal of Dr D Y Patil Vidyapeeth
59. Demonstrating the ability of GABAergic cells in the zona incerta to modulate motivation
    Laura Korobkova, Brian George Dias · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
60. Nutraceuticals: Plant-Based Nutrition for Health and Wellness
    Salma Sameh, Ashaimaa Yehia Moussa, Nada M. Mostafa, Abdel Nasser B. Singab · 2026 · Sustainability Sciences in Asia and Africa
61. Retinoic acid ameliorates chronic stress-induced behavioral deficits by modulating neuroinflammation and oxidative stress in mice
    Maryam Azarfarin, Ali Hassanzadeh, Sara Salatin, Kimia Motlagh Asghari, Samin Hamidi · 2026 · Gene Reports
62. Physical activity in the treatment-resistant depression and non-remitted depression: a systematic review of randomized controlled trials
    José Etxaniz‐Oses, Nagore Iriarte‐Yoller, Mikel Tous‐Espelosin, Sara Maldonado‐Martín · 2026 · F1000Research
63. An exploratory data-driven stratification of depression based on functional network connectivity and symptom profiles suggests heterogeneous responses to iTBS
    Jiang Wang, Shiying Wang, Zeyang Zhao, Nan Li, Bin Zhang · 2026 · BMC Psychiatry
64. A Toxina Botulínica Tipo A no Tratamento do Transtorno Depressivo Maior: Uma Revisão da Literatura
    Amanda Maura Fernandes de Oliveira, Karen Alessandra de Oliveira Fidélis, Samyr Machado Querobino · 2026 · ID on line REVISTA DE PSICOLOGIA
65. Berberine attenuates SPS-induced cognitive and affective deficits and corticolimbic injury in Wistar rats via restoration of BDNF and redox–inflammatory balance
    Godson Emeka Anyanwu, Precious E. Ekwueme, Ayugha Nsan, L Ezeugwu, Prisca Chiamaka Ogbe, Chinyere N. Anyanwu, Vivian Onyinye Ojiakor, Chima Paul Okechukwu Ugwu · 2026 · Nutritional Neuroscience
66. Obsessive‐Compulsive Symptoms Associated With Bupropion Treatment: A Case Series
    José Alfonso Ontiveros-Sánchez de la Barquera, Luis Alberto De La Garza García, Guillermo Sanchez Torres, Pablo Patricio Zárate‐Garza, Diego José Vázquez Ramos · 2026 · Case Reports in Psychiatry
67. Effects of Continuous Moderate Intensity Training and Fluoxetine on Neuroplasticity Biomarkers in the Brain of Wistar Rats with Depression
    Elvine Gunawan, Ronny Lesmana, Hanna Gunawan, AZIIZ MARDANARIAN ROSDIANTO, Leonardo Lubis, Veranita Pandia, Ambrosius Purba · 2026 · F1000Research
68. THE PSYCHEDELIC AND KETAMINE RENAISSANCE IN THE FACE OF THE CRISIS IN MODERN PSYCHIATRY
    Julia Osipowska, Marlena Kwolek, Alicja Judzińska, Bartosz Piech, Kamila Sobczyńska, Justyna Ignarska, Magda Terbosh, Sabina Kubicz `Mzabi, Emilia Trojanowska, Magdalena Dubaj · 2026 · International Journal of Innovative Technologies in Social Science
69. Deep brain stimulation for major depressive disorder: a systematic review and meta-analysis
    Felicia Manocchio, Martin R. Profant, Aram Abbasian, Jordan Enepekides, Jennifer S. Rabin, Maged Goubran, Ying Meng, Xingshan Cao, Sean M. Nestor, Clement Hamani et al. · 2026 · Nature Mental Health
70. Transcutaneous vagus nerve stimulation enhances reward-effort efficiency in severe major depressive disorder
    Paul Forbes, Emily S.L. Brandt, Mareike Aichholzer, Carmen Uckermark, Aicha Bouzouina, Leona Jacobsen, Jonathan Repple, Jonathan Kingslake, Christine Reif-Leonhard, Andreas Reif et al. · 2026 · Journal of Affective Disorders
71. Physical activity in the treatment-resistant depression and non-remitted depression: a systematic review of randomized controlled trials
    José Etxaniz‐Oses, Nagore Iriarte‐Yoller, Mikel Tous‐Espelosin, Sara Maldonado‐Martín · 2026 · F1000Research
72. Bipolar Spectrum Disorder
    Karen Hellwig · 2026 · Home Healthcare Now
73. Individualized pharmacogenomics for depressive episodes: A narrative review
    MICHEL HADDAD, Luiz Henrique Junqueira Dieckmann, Giovana Regina Weber Hoss, Jair de Jesus Mari, Allan Hunter Young, Mário F. Juruena · 2026 · Journal of Affective Disorders
74. Radiobiological And Clinical Comparison of Single-Session Versus Hypofractionated Gamma Knife Radiosurgery for Medically Refractory Trigeminal Neuralgia
    Mohammed Hassan Alewi, Siham Sabah Abdullah, Moneer K Faraj · 2026 · Jurnal MIPA dan Pembelajarannya
75. Demonstrating the ability of GABAergic cells in the zona incerta to modulate motivation
    Laura Korobkova, Brian George Dias · 2026 · eLife
76. Demonstrating the ability of GABAergic cells in the zona incerta to modulate motivation
    Laura Korobkova, Brian George Dias · 2026 · eLife
77. Resting-state fMRI-based machine learning for predicting SSRI treatment response in major depressive disorder
    Hu Yuxuan, Jinrui Gao, Yaoze Liu, Rui Zhong, Zixuan Wu, Juan Qiao · 2026 · BMC Psychiatry
78. Patient characteristics, treatment patterns and clinical response in patients with treatment resistant depression starting a new treatment in the clinical setting: a multicenter, observational study in Portugal
    Ricardo Moreira, Patrícia Frade, N. Campeão, Sofia Gomes, A. de M. Lopes, G. Lapa, João Vian, Ana Fonseca, F. Polido, Bernardo C. Barata et al. · 2026 · Frontiers in Psychiatry
79. Biomarkers for mood disorders: A scoping review of research from India
    Varshitha Tholasappa, Varna Pai Baidebettu, Hariprasad Ganapathy Vijaykumar, Preethi Veerappa Reddy, Rashmi Arasappa, Muralidharan Kesavan · 2026 · Indian Journal of Psychiatry
80. Real-world effectiveness and tolerability of desvenlafaxine in major depressive disorder: A multicentre prospective Italian national-cohort study
    Giacomo d’Andrea, Clara Cavallotto, Rita Allegretti, Matteo Lupi, Claudia Carmassi, Antonio Ventriglio, Diego Quattrone, Raffaella Zanardi, Stefano Barlati, Vassilis Martiadis et al. · 2026 · Psychiatry Research
81. Oncology Providers’ Perspectives on Psychedelic-Assisted Therapy
    Krishna S. Hanubal, A. Munjal, Jino Park, R. Banks, Esther Y. Choi, M. Hoyt, Jessi Humphreys, M. Mojtahedzadeh, J. Harris · 2026 · The American journal of hospice & palliative care
82. Psilocibina e neuroplasticidade: novas perspectivas terapêuticas para depressão resistente
    Leticia Almeida Castro, André Luiz Anjos Simões Júnior, Guilherme Gianizeli Corradi Simões, Vagner Rocha Simonin de Souza, Lucas Luís Meigre Dias Pereira, Ariely Lirio de Sousa Lacerda, Cristiane Lyrio da Silva · 2026 · Vértices
83. Esketamine Use and Attempted Suicide or Intentional Self-Harm Among Individuals with Treatment-Resistant Depression: A Retrospective Cohort Study
    You Wang, Alexandra S. Storaci, G. Caleb Alexander, Jason Brian Gibbons · 2026 · Drug Safety
84. Hippocampal metabolites illustrate greater potential for early response assessment to antidepressant therapy than the anterior cingulate cortex in major depressive disorder.
    Deepti Upadhyay, Vishwa Rawat, G. Hans, Shivam Pandey, P. Sharan, Uma Sharma · 2026 · Magnetic Resonance Imaging
85. Evaluation of Antidepressant Effects of Silibinin Alone and in Combination with Sertraline and Venlafaxine in Swiss Albino Mice
    Deepak Bharati, Jishaan Khan, Jegan Nadar, Nitin Kumar Sen, Dixitkumar Pualsa, Popat B Mohite · 2026 · Toxicology International
86. Case Report: Grade 2 oligodendroglioma presenting as treatment resistant major depressive disorder
    Matthew Herman, Amy Nuismer, For-Shing Lui · 2026 · Research Square
87. Beyond enrichment: pharmacogenetic heterogeneity in treatment-resistant depression
    Bradley Roberts, Aleksandra Miljevic, Lauren A. Hennessy, Caitlan A. Boax, Kyle Hoath, Chad Bousman, Sean D. Hood, Jennifer Rodger · 2026 · Pharmacogenetics and Genomics
88. Transcranial magnetic stimulation in the rehabilitation of patients with depression
    N. A. Pizov, N. V. Pizova · 2026 · Meditsinskiy sovet = Medical Council
89. 40-Hz chirp auditory stimulation alleviates chronic restraint stress-induced depression-like behaviors and restores disrupted gamma oscillations.
    Jun-Ling Wang, Xiao-Chen Zhang, Hai-Kuo Shi, Wan-Ting Guo, Shuang Liu, Ming Dong · 2026 · Progress in Neuro-psychopharmacology and Biological Psychiatry
90. Vitamin B6 augments antidepressant activity of venlafaxine by restoring cortical EEG oscillations, behavior and oxidative biomarkers in chronic unpredictable mild stress (CUMS)-induced model of depression-like behavior
    Fashwa Khan Tareen, Sana Javaid, Waseem Ashraf, Syed Muhammad Muneeb Anjum, Rana Muhammad Zahid Mushtaq, Asad Abrar, Faleh Alqahtani, Imran Imran · 2026 · Brain Research
91. Inflammation and specific symptoms of depression: cross-sectional sex-specific associations between C-reactive protein and symptoms of depression in the lifelines cohort study
    Naoise Mac Giollabhui, Ravi J. Kingan, Sara R. McLain, Catharina Annette Hartman, Richard T. Liu · 2026 · Brain Behavior and Immunity
92. Effectiveness of rTMS vs. Pharmacotherapy in Late-Life Treatment-Resistant Depression: An Observational Study of Individual Participant Data From Two Randomized Clinical Trials
    Erin Adler, Daniel M. Blumberger, Eric J. Lenze, Patrick J. Brown, Jordan F. Karp, Helen Lavretsky, Taeho Greg Rhee, Benoit H. Mulsant, Tyler S. Kaster · 2026 · American Journal of Psychiatry
93. Depression and antidepressant use are associated with prolonged recovery and increased opioid dependence following ulnar nerve transposition
    T. Parmar, Shriyaus Lingam, Mohammad Daher, Joseph Albert Abboud · 2026 · MUSCULOSKELETAL SURGERY
94. BindingDB Entry 50014598: Synthesis and biological evaluation of 1-(4-(piperazin-1-yl)phenyl)pyridin-2(1H)-one derivatives as potential SSRIs.
    BindingDB · 2022 · UC San Diego